1.26
전일 마감가:
$1.40
열려 있는:
$1.38
하루 거래량:
3.19M
Relative Volume:
4.33
시가총액:
$96.50M
수익:
$4.72B
순이익/손실:
$-123.85M
주가수익비율:
-0.0881
EPS:
-14.2981
순현금흐름:
$-303.12M
1주 성능:
-57.14%
1개월 성능:
-63.16%
6개월 성능:
-47.06%
1년 성능:
-82.02%
Accendra Health Inc Stock (ACH) Company Profile
명칭
Accendra Health Inc
전화
(804) 277-4304
주소
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ACH
Accendra Health Inc
|
1.26 | 246.60M | 4.72B | -123.85M | -303.12M | -14.30 |
|
MCK
Mckesson Corp
|
901.77 | 99.52B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
333.87 | 60.54B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
240.26 | 53.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
89.18 | 9.64B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
1.39 | 1.25B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-07-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 재개 | Citigroup | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-30 | 재개 | JP Morgan | Underweight |
| 2022-03-23 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2021-04-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-03-08 | 업그레이드 | Goldman | Sell → Buy |
| 2020-12-17 | 업그레이드 | UBS | Neutral → Buy |
| 2020-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-01-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-11-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2019-09-06 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-10 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-01-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2018-12-14 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-09-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | 다운그레이드 | CLSA | Outperform → Sell |
| 2018-04-10 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2017-11-02 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2016-03-24 | 업그레이드 | Goldman | Sell → Neutral |
| 2015-12-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2015-08-31 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | 개시 | HSBC Securities | Underweight |
| 2009-08-05 | 업그레이드 | Citigroup | Sell → Buy |
| 2008-12-01 | 다운그레이드 | HSBC Securities | Neutral → Underweight |
모두보기
Accendra Health Inc 주식(ACH)의 최신 뉴스
ACH|Accendra Health Ord Shs|Price:3.215|Chg%:+0.075 - TradingKey
Accendra Health names new CIO and chief procurement officer - Investing.com
Accendra Health Announces Leadership Appointments in IT and Procurement - Business Wire
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call - Business Wire
Accendra Health Ord Shs (ACH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Accendra Health Inc. (ACH) Edges Higher Amid Steady Sector Sentiment – Key Levels in FocusHigh Volume Node - po-news-eg.net
ACH|Accendra Health Ord Shs|Price:3.140|Chg%:+0.020 - TradingKey
Paradigm Capital Management Inc. NY Purchases New Position in Accendra Health, Inc. $ACH - MarketBeat
Accendra Health Inc Revenue Breakdown – MUN:6OM - TradingView
Accendra Health (ACH) Q2 2024 earnings summary - Quartr
Enterprise value to EBIT forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Enterprise value to EBIT forward of Accendra Health Inc – GETTEX:6OM - TradingView
Accendra Health files prospectus for $200M mixed shelf - scanx.trade
Accendra Health Files $200 Million Mixed Shelf Registration - Moomoo
Form S-3 Accendra Health Inc For: 15 July By Investing.com - Investing.com Nigeria
Price to earnings forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Inc. (ACH) Surges 7.27%: Bullish Momentum Tests Key ResistanceFundamental Weighted - dars.gov.et
Accendra Health (ACH) Has Home-Care Scale, but the Debt Stack Drives the Risk - AlphaStreet
Price to earnings forward of Accendra Health Inc – SWB:6OM - TradingView
Enterprise value to revenue forward of Accendra Health Inc – SWB:6OM - TradingView
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Concludes Exchange Offers for Senior Notes Due 2029 and 2030 - sekbernews.id
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Price to sales forward of Accendra Health Inc – SWB:6OM - TradingView
Accendra Health (ACH) Sheds 1.5% as Shares Approach Key Support ZoneLow Volume Node - dars.gov.et
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
ACH Q1 2026 Earnings: EPS Beat Surprises Market, Stock Jumps 4.68%Dividend Cut Risk - dars.gov.et
Accendra Health Inc. Q1 2026 Earnings: EPS Beats Estimates but Stock DeclinesNext Quarter Guidance - po-news-eg.net
Accendra Health Inc. (ACH) Slides Slightly as Shares Test Support Near $3.14Donchian Channel - dars.gov.et
Accendra Health, Inc.(NYSE: ACH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Index - marketscreener.com
Accendra Health Inc Actuals & Estimates (NYSE:ACH) - TradingView
ACHAccendra Health Inc Options - Finviz
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Value Benchmark - marketscreener.com
Accendra Health Completes Major Exchange Offer, Restructures Debt - TipRanks
Accendra Health reports near-complete tenders in exchange offers, issues new secured notes - TradingView
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health Reports Expiration of Exchange Offers, Final Tender Results - Moomoo
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
ACH Q1 2026 Earnings: EPS Beat Drives Positive Market Response Despite Revenue UncertaintyEPS Estimate Trend - dars.gov.et
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accendra Health Inc. (ACH) Q1 2026 Earnings: Strong EPS Beat Signals Operational ImprovementFiscal Year Earnings - dars.gov.et
Accendra Health Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes - Minichart
Accendra Health Completes Major Debt Exchange and Refinancing - TipRanks
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue DisclosureEarnings Per Share - newsline.com
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Australia
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health secures 99% participation in exchange offers - scanx.trade
Accendra Health Inc (ACH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Accendra Health Inc 주식 (ACH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
자본화:
|
볼륨(24시간):